Sanjay Kumar Bhadada Selected Research

Parathyroid Neoplasms (Parathyroid Neoplasm)

1/2022	Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.
9/2021	Parathyroid Carcinoma: An Experience from the Indian Primary Hyperparathyroidism Registry.
3/2021	Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry.
1/2021	GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
1/2020	Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
12/2019	Minimally invasive parathyroid carcinoma-A missing entity between parathyroid adenoma and carcinoma: Scintigraphic and histological features.
4/2019	Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity.
4/2018	Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT.
1/2018	Erratum to: Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT.
12/2017	Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjay Kumar Bhadada Research Topics

Disease

15	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2022 - 07/2013
14	Primary Hyperparathyroidism 01/2022 - 10/2009
8	Vitamin D Deficiency 07/2021 - 09/2014
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 02/2011
5	Hypercalcemia (Milk Alkali Syndrome) 10/2022 - 05/2012
5	Neoplasms (Cancer) 01/2022 - 03/2019
5	Diabetes Mellitus 03/2021 - 11/2016
5	Type 2 Diabetes Mellitus (MODY) 03/2021 - 06/2010
4	Osteoporosis 01/2021 - 05/2012
3	Inflammation (Inflammations) 04/2022 - 01/2018
3	Dysbiosis 01/2022 - 01/2018
3	Pancreatitis 01/2022 - 02/2014
3	Neoplasm Metastasis (Metastasis) 09/2021 - 07/2012
3	COVID-19 03/2021 - 11/2020
3	Hypophosphatemia 02/2021 - 07/2015
3	Adenoma (Adenomas) 01/2020 - 07/2013
3	Pain (Aches) 01/2019 - 05/2011
3	Anemia 09/2015 - 02/2011
2	Pituitary ACTH Hypersecretion 05/2021 - 10/2020
2	Carcinogenesis 01/2021 - 01/2020
2	Rheumatoid Arthritis 01/2021 - 07/2014
2	Femoral Neck Fractures 01/2021 - 05/2012
2	Hypertension (High Blood Pressure) 11/2020 - 10/2020
2	Acanthosis Nigricans 04/2020 - 12/2008
2	Osteomalacia 01/2020 - 01/2017
2	Papillary Thyroid Cancer 04/2018 - 01/2018
2	Celiac Disease (Celiac Sprue) 01/2018 - 12/2013
2	Bone Resorption 06/2017 - 12/2013
2	Wounds and Injuries (Trauma) 02/2017 - 05/2012
2	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 05/2012 - 01/2011
2	Hypoparathyroidism 01/2012 - 07/2011
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Lymphoma (Lymphomas) 03/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2022
1	Mobility Limitation (Difficulty Walking) 03/2022
1	Hypoglycemia (Reactive Hypoglycemia) 03/2022
1	Hypopituitarism (Sheehan's Syndrome) 03/2022
1	Camurati-Engelmann Syndrome (Progressive Diaphyseal Dysplasia) 03/2022
1	Nephrolithiasis 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Mucormycosis 12/2021
1	Oncogenic osteomalacia 10/2021
1	Disease Progression 09/2021
1	Cushing Syndrome 05/2021

Drug/Important Bio-Agent (IBA)

18	Parathyroid Hormone (Parathormone)IBA 01/2022 - 05/2012
11	CalciumIBA 09/2021 - 01/2012
8	Diphosphonates (Bisphosphonates)IBA 03/2022 - 05/2011
8	Vitamin D FDA LinkGeneric 01/2021 - 10/2013
6	Alkaline PhosphataseIBA 07/2021 - 12/2018
5	Insulin (Novolin)FDA Link 03/2022 - 10/2009
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2014
4	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022 - 10/2020
4	hydroxide ionIBA 01/2021 - 09/2014
4	calcium phosphateIBA 01/2021 - 02/2014
4	Phosphates (Orthophosphate)IBA 10/2019 - 01/2012
4	fluorocholineIBA 04/2019 - 12/2017
3	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2022 - 10/2009
3	Messenger RNA (mRNA)IBA 01/2022 - 07/2013
3	Calcium-Sensing ReceptorsIBA 01/2020 - 07/2013
3	25-hydroxyvitamin DIBA 12/2018 - 11/2013
2	LipopolysaccharidesIBA 04/2022 - 01/2022
2	ChromatinIBA 01/2022 - 01/2020
2	hydrogen sulfite (bisulfite)IBA 01/2022 - 10/2013
2	Histones (Histone)IBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2019
2	CreatinineIBA 01/2022 - 12/2018
2	isoprocarbIBA 09/2021 - 12/2019
2	Collagen Type I (Type I Collagen)IBA 01/2021 - 06/2017
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 12/2018 - 12/2017
2	CytokinesIBA 11/2018 - 06/2017
2	preproinsulinIBA 01/2018 - 03/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 02/2017
2	Pharmaceutical PreparationsIBA 02/2017 - 07/2011
2	Cyclin D1IBA 01/2017 - 07/2013
2	Zoledronic Acid (Zometa)FDA Link 07/2014 - 12/2013
2	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2013 - 07/2013
1	Denosumab FDA Link 10/2022
1	Interleukin-8 (Interleukin 8)IBA 04/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2022
1	CarbimazoleIBA 03/2022
1	Prednisolone (Predate)FDA LinkGeneric 03/2022
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 03/2022
1	Follicle Stimulating Hormone (Follitropin)FDA Link 03/2022
1	Testosterone (Sustanon)FDA Link 03/2022
1	Growth Hormone (Somatotropin)IBA 03/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	LipocalinsIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Tight Junction ProteinsIBA 01/2022
1	GlucocorticoidsIBA 12/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	COVID-19 VaccinesIBA 03/2021
1	Neutralizing AntibodiesIBA 03/2021

Therapy/Procedure

9	Parathyroidectomy 01/2022 - 10/2009
6	Therapeutics 01/2021 - 07/2012
2	Adrenalectomy 05/2021 - 10/2020
1	Radiotherapy 03/2022
1	Intraperitoneal Injections 01/2022